Effects of nepicastat upon dopamine-β-hydroxylase activity and dopamine and norepinephrine levels in the rat left ventricle, kidney, and adrenal gland-Reference-Cited by-同舟云学术

Effects of nepicastat upon dopamine-β-hydroxylase activity and dopamine and norepinephrine levels in the rat left ventricle, kidney, and adrenal gland

Published:2019-03-01 Issue:2 Volume:42 Page:118-125
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Catelas Diogo Nóbrega¹,Serrão Maria Paula¹²,Soares-Da-Silva Patricio¹²^ORCID

Affiliation:

1. Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty Medicine, University of Porto, Porto, Portugal

2. MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal

Funder

Foundation for Science and Technology (FCT) – Portugal

Foundation for Science and Technology

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10641963.2019.1583245

Reference37 articles.

1. Genetics of arterial hypertension and hypotension

2. New Approaches in the Treatment of Hypertension

3. Sympathetic nervous system

4. Adrenergic Nervous System in Heart Failure

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential;Aging and disease;2024

2. Insulin enhances contextual fear memory independently of its effect in increasing plasma adrenaline;Life Sciences;2023-09

3. Nepicastat, a dopamine-beta-hydroxylase inhibitor decreases blood pressure and induces the infiltration of macrophages and B cells in the heart of spontaneous hypertensive rats;2023-07-29

4. Lipopolysaccharide-binding protein expression is increased by stress and inhibits monoamine synthesis to promote depressive symptoms;Immunity;2023-03

5. Dopamine, Immunity, and Disease;Pharmacological Reviews;2022-12-08